Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
cHOD17 in Pediatric Classical Hodgkin Lymphoma
NCT03755804Phase 2Active, not recruiting
- Sponsor
- St. Jude Children's Research Hospital
- Start
- Dec 2018
- Primary completion
- Jan 2027
- Modality
- Monoclonal Antibodies, Antibody-Drug Conjugates (ADCs), Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of bendamustine, brentuximab vedotin in classical Hodgkin lymphoma (cHL), sponsored by St. Jude Children's Research Hospital. Started Dec 2018; status: active, not recruiting.
02
Drugs
bendamustinebrentuximab vedotin
03
Conditions
classical Hodgkin lymphoma (cHL)
Beyond the preview
Go deeper on NCT03755804.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03755804.